Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Regular | Regular |
| Fund house | Nippon India | HDFC |
| NAV | ₹24.8465 | ₹22.8170 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 12.2 years | 3.1 years |
| Expense ratio | 2.5% | 2.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 67.80 | 93.90 |
Returns
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | −10.64% | +12.87% |
| 3 months | −10.84% | +6.85% |
| 6 months | −7.65% | +17.20% |
| YTD | +10.31% | +32.43% |
| 1 year | +15.07% | +30.73% |
| 3 years (CAGR) | +15.22% | +29.16% |
| 5 years (CAGR) | +7.03% | — |
| 10 years (CAGR) | +8.91% | — |
| Since launch | +7.78% | +30.28% |
Risk
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | 14.5% | 15.8% |
| Downside volatility | 9.6% | 8.6% |
| Sharpe | 0.60 | 1.44 |
| Sortino | 0.91 | 2.64 |
| Calmar | 0.94 | 1.94 |
| Return / risk | 1.05 | 1.85 |
| Deepest fall | −30.92% | −15.07% |
| Days to recover | 518 | 133 |
| Below its high | −13.98% | +0.00% |
Against benchmark
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | +7.57% | +6.36% |
| Beta | 0.15 | 0.97 |
| R² | 2.7% | 85.0% |
| Up capture | 48.5% | 106.7% |
| Down capture | −5.5% | 74.4% |
| Tracking error | 19.8% | 6.1% |
| Information ratio | 0.15 | 0.97 |
| Treynor | 0.55 | 0.22 |
Consistency
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +56.97% | +64.96% |
| Middle 1-year | +10.97% | +21.84% |
| Worst 1-year | −27.90% | +0.52% |
| 1-year periods with a loss | 22.8% | 0.0% |
| Middle 3-year | +7.36% | +28.68% |
| Positive months | 66.7% | 69.4% |
| Best day | +7.05% | +3.19% |
| Worst day | −7.03% | −3.62% |
| Worst 5% day | −1.69% | −1.50% |
| Positive days | 51.5% | 58.1% |
| NAVs a year | 229 | 247 |
SIP of ₹10,000 a month
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | +12.62% | — |
| 5-year value | ₹8,28,841 | — |
| 3-year XIRR | +12.67% | +26.26% |
| 1-year XIRR | −3.38% | +39.84% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.